BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every ...
In January 2024, LEQEMBI was approved for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or mild dementia stage of disease (collectively referred to as ...
CNBC Select names the best lenders for non-QM loans, including New American Funding and CrossCountry Mortgage.
As colder weather approaches, Peoples Natural Gas is encouraging customers to apply early for heating assistance through the Dollar Energy Fund, which opens Oct. 1 for the 2025-26 winter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results